Latest fatty liver Stories
LEEDS, England, Nov.
The link between sleeping and obesity is drawn tighter as a new research published online in the FASEB Journal (http://www.fasebj.org/content/early/2010/11/19/fj.10-172080.abstract) study shows that what your mother ate when she was pregnant may make you obese or overweight by altering the function of genes (epigenetic changes) that regulate circadian rhythm.
Statistics from the Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/) rank mortality related to chronic liver disease and cirrhosis as the 12th most common cause of death in adults in the U.S.
Curcumin, a chemical that gives curry its zing, holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease.
Researchers at the University of Palermo in Italy provide the evidence that a higher visceral adiposity index scoreâ€”a new index of adipose dysfunctionâ€”has a direct correlation with viral load and is independently associated with both steatosis and necroinflammatory activity in patients with genotype 1 chronic hepatitis C (G1 CHC).
Estimates of the prevalence of liver disease suggest that oneâ€third of the United States population has nonâ€alcoholic fatty liver disease (NAFLD).
The association between obesity and gastrointestinal-related cancers and coronary artery disease; the link between an overweight or obese body mass index and the severity of Crohn's disease; and whether inflammatory bowel disease is an independent risk factor for coronary artery disease, were among the highlights of new research that was presented this week at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio.
NEW YORK, July 28 /PRNewswire/ -- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the signing of a cooperative research and development agreement (CRADA) with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health to conduct a double blind, multi-center, study to evaluate the effects of obeticholic acid in patients...
A study conducted by researchers at Johann Wolfgang Goethe University in Frankfurt, Germany found that high doses of ursodeoxycholic acid (UDCA), suggested by some studies to have a beneficial effect on nonalcoholic steatohepatitis (NASH), does not improve overall histology in these patients.
A multidisciplinary research team from the Instituto Biodonostia made up by digestologists, epidemiologists and researchers of the Experimental Unit evaluates the use of a method so far employed in the food industry to improve the diagnosis of hepatic steatosis.
- A poem in which the author retracts something said in an earlier poem.